These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 27978925)

  • 1. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
    Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis.
    Ju HY; Jang JY; Jeong SW; Woo SA; Kong MG; Jang HY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Jin SY; Kim HS; Kim BS
    Clin Mol Hepatol; 2012 Jun; 18(2):213-8. PubMed ID: 22893872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
    Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
    Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
    Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
    Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
    Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
    Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.
    Joshita S; Yoshizawa K; Umemura T; Ohira H; Takahashi A; Harada K; Hiep NC; Tsuneyama K; Kage M; Nakano M; Kang JH; Koike K; Zeniya M; Yasunaka T; Takaki A; Torimura T; Abe M; Yokosuka O; Tanaka A; Takikawa H;
    J Gastroenterol; 2018 Sep; 53(9):1079-1088. PubMed ID: 29476251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
    Weber S; Benesic A; Rotter I; Gerbes AL
    Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group.
    Omagari K; Masuda J; Kato Y; Nakata K; Kanematsu T; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Koga M; Yano M; Kohno S
    Intern Med; 2000 Dec; 39(12):1008-12. PubMed ID: 11197782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation.
    Shen Y; Lu C; Men R; Liu J; Ye T; Yang L
    Can J Gastroenterol Hepatol; 2018; 2018():3513206. PubMed ID: 29744332
    [No Abstract]   [Full Text] [Related]  

  • 12. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
    Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
    J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of autoimmune hepatitis patients with poor response to treatment].
    Zhang HW; Liu HM; Lin R; Zhou L; Zhang J; Liu WT
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):755-759. PubMed ID: 29108204
    [No Abstract]   [Full Text] [Related]  

  • 14. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
    Church RJ; Watkins PB
    Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
    Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
    Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis.
    Yang J; Yu YL; Jin Y; Zhang Y; Zheng CQ
    World J Gastroenterol; 2016 Sep; 22(33):7579-86. PubMed ID: 27672278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
    Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
    Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
    Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
    Asgarshirazi M; Shariat M; Sheikh M
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury.
    He T; Ren L; Gong M; Guo Y; Wang L; Xiao X; Wang R; Bai Z
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102009. PubMed ID: 35977662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.